Given that the execs of alterity have all worked and sold a...

Given that the execs of alterity have all worked and sold a neuro drug too Teva therapeutics. I went to see if there was any association "sneakily" with Alterity.

Although I could not see any current association, I did notice that Teva were also looking into treating MSA with their own product.

The benefit for Alterity is that we are weeks away from ending our phase 2 study, and Teva is just beginning there phase 2 study which will end late 2027.

Interestingly enough, they had a study below showing that interfering with a-syn aggregation showed an
increase in anti melanoma immune responses.

Could this possibly be an extra treatment for ATH434 ???.


https://pubmed.ncbi.nlm.nih.gov/38950202/

https://delta.larvol.com/Products/?ProductId=139c80eb-f06e-4908-b85d-d5e35f82ed61

I also note there are was another study relating a-syn too melanoma....interesting